Email This Article

Headlines & Perspectives
Genentech Suspends Recruitment in Avastin Trial
By TSC Staff
02/13/06 - 02:30 PM EST
A data-monitoring board urges the step after several patients die.
Recipient's Email Address(es)
(Separate multiple addresses with a comma)
Your Email Address
Send a copy to myself
Your Message (optional)

Privacy Policy

The information entered on this page will not be used to send unsolicited email and will not be sold to a 3rd party.

Dow Jones S&P 500 NASDAQ 10-Year Note
10,218.70 1,089.89 2,145.23 34.63
Oil *
77.75
DOWN
8.24
DOWN
3.18
DOWN
8.83
DOWN
0.23
10 Yr
3.46%
SPDR Gold
107.95
-0.08%
-0.29%
-0.41%
-0.66%
Data delayed 20 minutes

Brokerage Partners